Related references
Note: Only part of the references are listed.Autoantibodies in Heart Failure and Cardiac Dysfunction
Ziya Kaya et al.
CIRCULATION RESEARCH (2012)
Targeting the F1Fo ATP Synthase: Modulation of the Bodys Powerhouse and Its Implications for Human Disease
John A. Johnson et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Role of β1-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy
Michael Dandel et al.
IMMUNOBIOLOGY (2012)
Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy
Andreas O. Doesch et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy
Lars R. Herda et al.
AMERICAN HEART JOURNAL (2010)
Complete Elimination of Cardiodepressant IgG3 Autoantibodies by Immunoadsorption in Patients With Severe Heart Failure
Akiyasu Baba et al.
CIRCULATION JOURNAL (2010)
Fc gamma-Receptor IIa Polymorphism and the Role of Immunoadsorption in Cardiac Dysfunction in Patients With Dilated Cardiomyopathy
A. Staudt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies
Christiane Trimpert et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Therapeutic Plasma Exchange a Potential Strategy for Patients with Advanced Heart Failure
Guillermo Torre-Amione et al.
JOURNAL OF CLINICAL APHERESIS (2010)
Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure
Rosemary C. She et al.
CARDIOVASCULAR PATHOLOGY (2009)
Effect of the Soluble TNF-Antagonist Etanercept on Tumor Necrosis Factor Bioactivity and Stability
Douglas L. Mann et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)
Cytokines and myocardial dysfunction: State of the art
Ayman A. El-Menyar
JOURNAL OF CARDIAC FAILURE (2008)
Fcγ receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardlomyopathy
Alexander Staudt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prospective familial assessment in dilated cardiomyopathy - Cardiac autoantibodies predict disease development in asymptomatic relatives
Alida L. P. Caforio et al.
CIRCULATION (2007)
The role of intravenous immunoglobulin in the treatment of chronic heart failure
Pal Aukrust et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium
Guilherme H. M. Oliveira et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship
Rahat S. Warraich et al.
FASEB JOURNAL (2006)
Role of immunoglobulin G3 subclass in dilated cardiomyopathy:: Results from protein A immunoadsorption
A Staudt et al.
AMERICAN HEART JOURNAL (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy
A Staudt et al.
CIRCULATION (2002)
Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: Immunoglobulin G3 and clinical correlates
RS Warraich et al.
AMERICAN HEART JOURNAL (2002)
Complement activation in patients with congestive heart failure -: Effect of high-dose intravenous immunoglobulin treatment
P Aukrust et al.
CIRCULATION (2001)
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure -: Modulatory effect of intravenous immunoglobulin
JK Damås et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
B Bozkurt et al.
CIRCULATION (2001)
Share Paper
